Galenika marks 77 years with growth in the markets of the region and further internationalization of business
07/27/2022 • Customer news
In the first half of 2022, the Galenika company, which is part of the Brazilian NC Group, recorded a significant expansion of its product portfolio, growth in regional markets and further modernization of operations. This July, the company marked 77 years of successful business and leadership in the pharmaceutical industry. On the Serbian market, Galenika achieved a 12 percent increase in sales compared to the same period last year, while in the markets of the regions where Galenika operates (Bosnia and Herzegovina, Montenegro, North Macedonia, Albania) sales increased by as much as 29 percent.
In Serbia and the region, 10 new products were registered this year, while 29 were put on the market, and by the end of the year, the launch of 36 more products is planned. Galenika successfully operates in 15 international markets in Europe, the Middle East and Africa. Six products were registered on the EU market, where the first export of dietary supplements was achieved, and offices in Croatia and Slovenia were opened.
For more infomation, visit the link.